BNTX BioNTech SE Stock Quote

BNTX [NASD]

Index	-	P/E	14.69	EPS (ttm)	18.95	Insider Own	1.18%	Shs Outstand	244.06M	Perf Week	12.38%
Market Cap	68.22B	Forward P/E	7.42	EPS next Y	37.49	Insider Trans	0.00%	Shs Float	215.94M	Perf Month	-21.15%
Income	4.72B	PEG	-	EPS next Q	10.39	Inst Own	16.70%	Short Float	1.06%	Perf Quarter	-2.77%
Sales	9.01B	P/S	7.57	EPS this Y	107.10%	Inst Trans	0.97%	Short Ratio	0.55	Perf Half Y	59.37%
Book/sh	26.05	P/B	10.68	EPS next Y	7.93%	ROA	95.10%	Target Price	332.87	Perf Year	222.30%
Cash/sh	4.33	P/C	64.32	EPS next 5Y	-	ROE	158.10%	52W Range	75.35 - 464.00	Perf YTD	241.44%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	4.90%	52W High	-40.01%	Beta	-
Dividend %	-	Quick Ratio	2.60	Sales past 5Y	-	Gross Margin	85.00%	52W Low	269.42%	ATR	17.76
Employees	2500	Current Ratio	2.70	Sales Q/Q	12630.20%	Oper. Margin	76.20%	RSI (14)	49.45	Volatility	6.45% 6.20%
Optionable	Yes	Debt/Eq	0.22	EPS Q/Q	-	Profit Margin	52.40%	Rel Volume	0.84	Prev Close	286.36
Shortable	Yes	LT Debt/Eq	0.09	Earnings	Nov 09 BMO	Payout	0.00%	Avg Volume	4.20M	Price	278.34
Recom	2.50	SMA20	5.75%	SMA50	-11.91%	SMA200	31.81%	Volume	3,546,638	Change	-2.80%

Oct-22-21

Initiated

Deutsche Bank

Hold

$250

Oct-07-21

Initiated

Jefferies

Hold

$230

Aug-11-21

Upgrade

Bryan Garnier

Neutral → Buy

$451

Jul-19-21

Resumed

Wolfe Research

Outperform

$248

Jun-16-21

Downgrade

Redburn

Neutral → Sell

$146

May-18-21

Initiated

Goldman

Neutral

$173

May-11-21

Downgrade

Bryan Garnier

Buy → Neutral

$135 → $206

Dec-01-20

Downgrade

BofA Securities

Buy → Neutral

$123 → $126

Aug-03-20

Resumed

Berenberg

Buy

$98

Jul-21-20

Upgrade

BofA Securities

Neutral → Buy

$71 → $105

Jun-30-20

Downgrade

H.C. Wainwright

Buy → Neutral

May-19-20

Upgrade

H.C. Wainwright

Neutral → Buy

$48 → $69

Apr-28-20

Downgrade

BofA/Merrill

Buy → Neutral

$46 → $51

Mar-18-20

Downgrade

JP Morgan

Overweight → Neutral

$23 → $33

Mar-09-20

Initiated

H.C. Wainwright

Neutral

$30

Jan-24-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

Jan-22-20

Downgrade

UBS

Buy → Neutral

$35

Nov-05-19

Initiated

Wolfe Research

Outperform

Nov-04-19

Initiated

UBS

Buy

$21

Nov-04-19

Initiated

SVB Leerink

Outperform

Oct-23-21 12:00AM	The Unlikely Outsiders Who Won the Race for a Covid-19 Vaccine The Wall Street Journal
Oct-22-21 10:05PM	Pfizer-BioNTech Covid-19 Vaccine for Young Kids Satisfied FDA Criteria, Agency Says The Wall Street Journal
06:48PM	'We're definitely not doing enough' to help global vaccinations: Former US Commerce Sec. Yahoo Finance
05:01PM	Moderna Slapped With Sell Rating Despite CDC Authorization For Covid Boosters Investor's Business Daily
03:32PM	COVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines may confer greater protection Reuters
03:01PM	Pfizer says vaccine is 90.7% effective in kids aged 5 to 11: BBG Yahoo Finance Video
10:43AM	Q3 Earnings Season Moving Along Zacks
10:32AM	Pfizer and BioNTech Covid Vaccine Is Nearly 91% Effective in Children Barrons.com
10:06AM	Pfizer's (PFE) Comirnaty Booster Dose Achieves 95.6% Efficacy Zacks
09:46AM	Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots Reuters
08:30AM	UPDATE 3-FDA says benefits outweigh risks for Pfizer/BioNTech COVID-19 vaccine in children Reuters
07:48AM	Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children Reuters
06:49AM	Pfizer-BioNTech Covid Vaccine Shows Efficacy Above 90% for Kids TheStreet.com
05:51AM	Why BioNTech and RedHill Are Soaring This Week, While Novavax Is Sinking Motley Fool
Oct-21-21 04:08PM	Pfizer-BioNTech Covid Booster Shines As CDC Discusses Mix-And-Match Plan Investor's Business Daily +6.29%
03:50PM	Why BioNTech Stock Jumped Today Motley Fool
11:27AM	Why BioNTech Shares Are Rising Benzinga
09:44AM	UPDATE 3-Pfizer, BioNTech say COVID-19 booster shot showed high efficacy in large study Reuters
09:38AM	Pfizer-BioNTech Covid-19 Booster Shot Was 95.6% Effective in Large Trial, Companies Say The Wall Street Journal
09:30AM	Pfizer Covid-19 Booster Found to Restore Efficacy Back to Near 96% Barrons.com
08:45AM	Moderna Stock Is Rising After FDA Authorization of Mix-and-Match Boosters Barrons.com
07:21AM	Pfizer, BioNTech Report 95.6% Efficacy for Covid Vaccine Booster TheStreet.com
07:02AM	Novartis Extends Fill/Finish Support For Pfizer/BioNTech COVID-19 Vaccines Benzinga
06:57AM	Pfizer and BioNTech say Phase 3 trial found booster dose of COVID vaccine had 95.6% efficacy against disease MarketWatch
06:45AM	Pfizer, BioNTech report high efficacy of COVID-19 booster shot in study Reuters
06:45AM	Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine Business Wire
04:16AM	Pfizer vaccine very effective against Delta variant in adolescents in Israel - study Reuters
Oct-20-21 07:32PM	Moderna and J&J Covid-19 Boosters, Mixing and Matching Authorized by the FDA The Wall Street Journal
02:39PM	Doctor on Covid-19: This is a virus that is really here to stay Yahoo Finance Video
02:14PM	Covid-19 Vaccine for Kids Ages 5-11 to Be Given at Pediatric Offices, Schools Once Authorized The Wall Street Journal
08:55AM	UPDATE 2-U.S. readies plan to vaccinate kids ages 5-11 against COVID-19 Reuters
Oct-19-21 01:00PM	Pfizer/BioNTech COVID-19 vaccine highly protective in 12-18 age group - U.S. CDC study Reuters
06:34AM	Vaccine-Makers Up on Likely FDA OK for Mix and Match Covid Booster Investing.com
05:52AM	Why Johnson & Johnson Will Be a Bigger Winner With Boosters Than Pfizer and Moderna Motley Fool
Oct-18-21 07:29PM	Pfizer CEO says hes gotten a COVID vaccine booster shot and most of us will, too MarketWatch +5.41%
01:17PM	Is Pfizer Stock A Buy As 'Open Season' Begins On Covid Booster Shots? Investor's Business Daily
10:29AM	J&J, Moderna COVID-19 Booster Jabs Near FDA Authorization Zacks
Oct-16-21 09:01AM	Europe Recommends Pfizer Boosters for Ages 18 and Up: Could the U.S. Soon Follow? Motley Fool
Oct-15-21 05:47PM	NIH director on why Moderna's COVID-19 vaccine for teens is on hold Yahoo Finance
04:28PM	FDA Delays Moderna Covid-19 Vaccine for Adolescents to Review Rare Myocarditis Side Effect The Wall Street Journal
02:51PM	NIH Director: I would like to see a lot more vaccine manufacturing in low- and middle-income countries Yahoo Finance
10:01AM	UPDATE 1-Pfizer/BioNTech submit data to EMA for COVID-19 vaccine in young children Reuters
08:18AM	The Zacks Analyst Blog Highlights: Southwest Airlines, Delta Air Lines, Moderna, Pfizer and BioNTech Zacks
06:55AM	Pfizer's Next mRNA Vaccine Candidate Goes Beyond COVID-19 Motley Fool
Oct-14-21 05:45PM	BioNTech SE Sponsored ADR (BNTX) Gains But Lags Market: What You Should Know Zacks
05:45PM	Why Moderna Stock Trounced the Market Today Motley Fool
04:23PM	Doctor: Just a 'matter of time' before another COVID-19 surge Yahoo Finance Video
03:56PM	Kyrie Irving won't play for the Brooklyn Nets until vaccinated Yahoo Finance Video
02:37PM	Doctor on Covid-19: Let history guide our future actions Yahoo Finance Video
12:48PM	Lack of US COVID-19 data is 'red meat' for anti-vaccine movement: Expert Yahoo Finance
Oct-13-21 04:24PM	'Mixing' COVID-19 vaccines triggers a stronger immune response, preliminary NIH study says MarketWatch
02:32PM	U.S. to open Canada, Mexico borders for vaccinated visitors Yahoo Finance Video
06:32AM	An FDA Advisory Panel Will Debate Moderna and J&J Boosters This Week Barrons.com
06:30AM	Can Pfizer Beat Moderna in mRNA Vaccines? Motley Fool
Oct-12-21 05:31PM	eMed CEO discusses what's next for COVID-19 testing Yahoo Finance Video
02:24PM	An FDA committee will discuss Moderna boosters. Here's what to expect American City Business Journals
11:30AM	Has BioNTech SE Sponsored (BNTX) Outpaced Other Medical Stocks This Year? Zacks
04:00AM	FDA Advisory Panel Will Debate J&J and Moderna Boosters This Week Barrons.com
Oct-11-21 06:14PM	International SOS SVP details where doctors have been needed most Yahoo Finance Video
03:10PM	Pfizer-BioNTech Covid-19 Vaccine Is Worlds Preferred Shot The Wall Street Journal
Oct-08-21 08:00PM	These Are the Stocks to Watch as Covid Enters Its Next Phase Bloomberg
04:27PM	Italy widens COVID-19 vaccine booster campaign to frail and over 60s Reuters
02:32PM	Studies claim Pfizer vaccine is less effective after a few months Yahoo Finance Video
10:07AM	Covid-19 Vaccine Boosters Are Outpacing First Doses. What Vaccine Stocks Are Doing. Barrons.com
09:24AM	Covid-19 Vaccine Boosters Now Outpace First Doses, CDC Data Show Barrons.com
Oct-07-21 11:16PM	REFILE-Malaysia approves Pfizer-BioNTech vaccine for booster dose Reuters
04:23PM	'Administrative hurdles' could delay pediatric vaccine distribution: Doctor Yahoo Finance Video
04:05PM	Vaccine Stocks Pop As Pfizer, BioNTech Seek OK To Vaccinate Young Children Investor's Business Daily
01:48PM	'Vaccine mandates are proving to work: Doctor on Covid-19 Yahoo Finance Video
10:56AM	Pfizer, BioNTech Seek Approval For COVID-19 Vaccine In Kids Aged 5-11: Reuters Benzinga
10:46AM	News that children could soon be eligible for Pfizer-BioNTech vaccine cheers parents, as Biden pushes vaccine requirements in Chicago MarketWatch
10:01AM	Pfizer and BioNTech Asked FDA to Authorize Vaccine for Children Barrons.com
08:46AM	Pfizer, BioNTech file for FDA authorization for their COVID-19 vaccine in children MarketWatch
08:40AM	UPDATE 4-Pfizer, BioNTech seek U.S. COVID-19 vaccine clearance for children 5-11 Reuters
08:11AM	Pfizer, BioNTech ask U.S. regulators to OK COVID-19 vaccine for kids Reuters
06:51AM	Pfizer Seeks FDA Emergency-Use Approval for Covid Vaccine for Kids 5 to 11 TheStreet.com
02:38AM	UPDATE 4-Moderna plans African vaccine plant as drugmakers urged to help poorest Reuters
Oct-06-21 04:28PM	Why BioNTech Stock Sank Today Motley Fool -5.59%
02:32PM	Mixing & matching covid boosters might be a great opportunity: Doctor Yahoo Finance Video
11:42AM	Vaccine Stocks Slip Fourth Day in a Row. Heres Why. Barrons.com
10:34AM	Moderna (MRNA) Gets EMA Authorization for SpikeVax Third Dose Zacks
08:28AM	Biotech Stock Roundup: MRNA's Vaccine Update, GILD's CAR T Therapy Label Expansion Zacks
07:10AM	Shares of Vaccine Makers Continue to Reel Under Mercks Covid Drug Potential Investing.com
Oct-05-21 06:09AM	Ocugen Stock Up on Development Pact for Covid Vaccine Candidate TheStreet.com
05:55AM	Does the Sell-Off of BioNTech and Moderna Stocks Present a Buying Opportunity? Motley Fool
05:11AM	J&J Gains on Seeking FDA Nod for Covid Booster for Adults Investing.com
Oct-04-21 06:30PM	Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months -study Reuters
12:10PM	Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union GlobeNewswire
11:17AM	New Vaccines Might Be Needed in 2022, BioNTech CEO Says. Vaccine Stocks Are Still Getting Crushed. Barrons.com
11:07AM	BioNTech (BNTX) Begins Dosing in mRNA Cancer Vaccine Study Zacks
11:03AM	UPDATE 3-EU regulator backs mRNA vaccine booster for people with weak immunity Reuters
10:44AM	Vaccine Stocks Down Following Merck's COVID-19 Pill Success Zacks
09:56AM	New Covid Vaccine May be Needed Next Year, BioNTech CEO Says TheStreet.com
09:54AM	Why BioNTech Shares Are Trading Lower Again Today Benzinga
08:10AM	BioNTech CEO Predicts New Vaccines Needed in 2022. Covid-19 Vaccine Stocks Are Still Falling. Barrons.com
06:38AM	Facebook Whistleblower Fires More Shots. Will Its Valuation Suffer? Barrons.com
02:58AM	BioNTech CEO reportedly says a different COVID vaccine may be needed by next year MarketWatch
Oct-03-21 06:51PM	Democrats Still Negotiating $3.5 Trillion Reconciliation Bill Barrons.com
Oct-02-21 08:00AM	Take a Look at the Top-Performing Biotech ETFs YTD Zacks
Oct-01-21 04:47PM	U.S. eyes Israeli military data for Pfizer COVID-19 booster safety Reuters -6.67%

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116 for non-small cell lung cancer.It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122), which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT153 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT221 for other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II a clinical trial to treat multiple solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody, which is in Phase I/IIa clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; prophylactic vaccine for COVID-19 and Influenza; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Genevant Sciences GmbH; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; and Regeneron Pharmaceuticals, Inc. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience